Inhibitory Effect of 2‐0‐Octadecylascorbic Acid in Agglutination Assay with Concanavalin A; Short‐term Examination of Rat Urinary Bladder Carcinogenesis

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A derivative of ascorbic acid, 2‐O‐octadecylascorbic acid (CV‐3611), is a strong scavenger of active oxygen species. We examined the effect of CV‐3611 on a short‐term test of bladder Carcinogenesis, using Concanavalin A (Con A) ‐dependent agglutination of isolated bladder epithelial cells. Rats were given 0.01%N ‐butyl‐N(4‐hydroxybutyl)nitrosamine (BHBN) for 1 week, and then 5% sodium saccharin or 2% DL‐tryptophan or 0.01% BHBN alone or with 0.002, 0.006 or 0.02% CV‐3611 for 3 weeks. Treatment with CV‐3611 reduced the effects of the bladder tumor promoters sodium saccharin and DL‐tryptophan by 48–86 and 65–87%, respectively. CV‐3611 also reduced the number of aggregates of bladder epithelial cells from rats treated with BHBN for 4 weeks. These results suggest that CV‐3611 has a suppressive effect on rat bladder Carcinogenesis. Copyright © 1991, Wiley Blackwell. All rights reserved

Cite

CITATION STYLE

APA

Suzuki, M., Wakabayashi, K., Sone, H., Kushida, H., Sugiyama, K., Kakizoe, T., … Sugimura, T. (1991). Inhibitory Effect of 2‐0‐Octadecylascorbic Acid in Agglutination Assay with Concanavalin A; Short‐term Examination of Rat Urinary Bladder Carcinogenesis. Japanese Journal of Cancer Research, 82(4), 386–389. https://doi.org/10.1111/j.1349-7006.1991.tb01860.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free